Market Place
Sourcing Support
Convergent Therapeutics Ships Actinium 225 for CONVERGE-01 Trial
18 Nov 2024 //
PR NEWSWIRE
Convergent Therapeutics Treats First Patient in Phase II Trial
24 Sep 2024 //
PR NEWSWIRE
NorthStar And Convergent Expand Collaboration On CONV01-?
13 Aug 2024 //
BUSINESSWIRE
Convergent Appoints Scott Myers as Chairman of its Board of Directors
04 Mar 2024 //
PR NEWSWIRE
Convergent Therapeutics Expands Leadership Team
06 Sep 2023 //
PR NEWSWIRE
Convergent to Announce Clinical Trial Updates on its Lead Candidate at ASCO
25 May 2023 //
PR NEWSWIRE
Convergent raises $90M to develop its radiopharmaceutical for prostate cancer
05 May 2023 //
BIOPHARMADIVE
Convergent Therapeutics Announces $90 Million Series A Financing
03 May 2023 //
BUSINESSWIRE
Convergent circles up $90M for cancer radiopharmaceuticals
03 May 2023 //
FIERCE BIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.